The latest biotech news

News and Trends 25 Feb 2020

European Researchers to Make Light Bulbs using Bacteria

A team of scientists from Austria, Spain, and Italy is working to make LED light bulbs out of proteins produced by bacteria. Light-emitting diodes, or LEDs, are widely seen as a key tool for making lighting eco-friendly because they are more energy-efficient than traditional bulbs. However, the coatings of these devices — designed to absorb […]

February 25, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 25 Feb 2020

Update: Janssen and Maze Jump on Board Finnish Genomics Project

Update (25/02/2020): Janssen and the US company Maze Therapeutics are the latest pharma companies to sign up as partners in the public-private genomics collaboration FinnGen. FinnGen’s pharma partners now total 11, including Sanofi and GSK, which joined early last year. Published 23/01/2019: Sanofi and GSK have joined up with a project collecting genomic and health […]

February 25, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 24 Feb 2020

Adrenomed’s Antibody Drug Scores Hit in Phase II Septic Shock Trial

German biotech Adrenomed reports that its first-in-class antibody drug adrecizumab was well-tolerated by septic shock patients and met its primary goal in a phase II trial. The company says it will release more detailed trial data in a peer-reviewed paper later in the year, but states that patients given adrecizumab, as opposed to placebo, had […]

February 24, 2020 - 3 minutesmins - By Helen Albert

News and Trends 20 Feb 2020

Immatics Partners GSK in Deal Worth €1B to Develop Cancer Therapies

The German biotech Immatics will partner with GSK and could receive more than €1B from the big pharma for developing cancer immunotherapies based on engineered immune T-cells. Immatics will collaborate with GSK to develop two T-cell therapies that express a protein engineered to detect cancer antigens and kill cancer cells. In return, Immatics will receive […]

February 20, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 19 Feb 2020

Belgian Biotech Raises €50M to Make Gene Therapy Manufacturing Cheaper

An equity investment worth up to €50M will push to market Univercells’ manufacturing technology, which is designed to reduce the costs of viral vector production for gene therapies. The investment comes from Gamma Biosciences, an investment platform supported by the US investor KKR. Gamma Biosciences aims to acquire and invest in businesses developing gene and […]

February 19, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 18 Feb 2020

OncoDNA Secures €19M to Progress Precision Cancer Treatment Technology

Belgian biotech OncoDNA has raised €19M in Series B funding to further develop its cancer diagnostic and therapeutic decision-making software. The funding was led by Vesalius Biocapital, a Luxembourg-based VC investor, Swiss VC firm Swisscanto Invest by Zürcher Kantonalbank, and Belgian VC company SFPI-FPIM. Early investors in the company such as CPH Bank also contributed […]

February 18, 2020 - 2 minutesmins - By Helen Albert

News and Trends 17 Feb 2020

UK Biotech Closes €50M Series A for GPCR Drug Discovery

Oxford-based OMass Therapeutics has extended its Series A round by €33M to fund the spectrometry-assisted development of drugs targeting G protein-coupled receptors. OMass Therapeutics’s Series A initially raised €17M in late 2018. The new funds bring this up to €50M (£41.5M). Investors in the most recent fundraise included the UK VC firm Syncona — which […]

February 17, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 14 Feb 2020

Italian Investment Firm AurorA Science Launches to Support Early Stage Biotechs

Italian technology transfer company AurorA-TT has joined forces with drug discovery companies Rottapharm Biotech and Italfarmaco to launch the biotech investment enterprise AurorA Science to support early stage biotechs. The partnership plans to invest €1–5M in each of one or two European start-ups this year. It is particularly focusing on promising biotechs in any area […]

February 14, 2020 - 2 minutesmins - By Laura Cowen

News and Trends 14 Feb 2020

Novozymes Launches Super Robust Yeast to Maximize Biofuel Production

The Danish industrial biotech company Novozymes has announced the launch of its latest non-GM yeast technology, Innova Fit, which it says reduces biofuel production bottlenecks caused by conventional and basic yeast. Biofuels, including ethanol, are a renewable energy source being used as a replacement for fossil fuels, with substantially reduced CO2 emissions, particularly in the transport […]

February 14, 2020 - 3 minutesmins - By External Contributor

News and Trends 13 Feb 2020

French Partnership Deploys AI for Antibody Drug Discovery

French companies OSE Immunotherapeutics and MAbSilico are teaming up to drive the discovery of new antibody drugs using artificial intelligence. The three-year partnership will use artificial intelligence, or AI, in six programs designed to accelerate the development of therapeutic monoclonal antibodies (mAbs) that can target cancer and autoimmune diseases. AI can improve the efficiency of […]

February 13, 2020 - 2 minutesmins - By External Contributor

automation arctoris molecule drug discovery

News and Trends 13 Feb 2020

UK-Swiss Collaboration to Boost Biotech Profits with Automation

A partnership between the UK lab automation company Arctoris and Swiss software firm Molecule aims to make it easier to share drug intellectual property in a time of declining returns in pharma. The pharmaceutical industry is struggling with the rising costs of developing new drugs. In fact, the return on investment for drug discovery is […]

February 13, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 12 Feb 2020

Charcoal-Based Treatment Can Protect Gut Microbiome from Antibiotics

Ingestible pellets containing a charcoal-like treatment — designed by the French company Da Volterra — can stop the microbiome from being disrupted in hospitalized patients treated with antibiotics. The treatment also showed the potential to reduce the risk of Clostridium difficile gut infections in a phase II trial. When patients are given antibiotics for infections, […]

February 12, 2020 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

European Researchers to Make Light Bulbs using Bacteria

Update: Janssen and Maze Jump on Board Finnish Genomics Project

Adrenomed’s Antibody Drug Scores Hit in Phase II Septic Shock Trial

Immatics Partners GSK in Deal Worth €1B to Develop Cancer Therapies

Belgian Biotech Raises €50M to Make Gene Therapy Manufacturing Cheaper

OncoDNA Secures €19M to Progress Precision Cancer Treatment Technology

UK Biotech Closes €50M Series A for GPCR Drug Discovery

Italian Investment Firm AurorA Science Launches to Support Early Stage Biotechs

Novozymes Launches Super Robust Yeast to Maximize Biofuel Production

French Partnership Deploys AI for Antibody Drug Discovery

UK-Swiss Collaboration to Boost Biotech Profits with Automation

Charcoal-Based Treatment Can Protect Gut Microbiome from Antibiotics

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!